Home » Company » Genetic testing company 23andMe to go public via merger with Richard Branson's SPAC in $3.5 billion deal - MarketWatch

By gundri aman Thursday, February 4, 2021 Company

Genetic testing company 23andMe to go public via merger with Richard Branson's SPAC in $3.5 billion deal - MarketWatch

Bagikan Berita Ini

0 Response to "Genetic testing company 23andMe to go public via merger with Richard Branson's SPAC in $3.5 billion deal - MarketWatch"

Post a Comment

Subscribe to: Post Comments (Atom)